iQure Pharma
PrivateLast Round
Seed Round
Jun 3, 2026
Total Funding Raised
$7.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iQure Pharma is a biotechnology company that develops innovative therapeutics for central nervous system disorders by restoring glutamate homeostasis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iQure Pharma Comparables
Compare iQure Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mentara Bio Inc. | 86% | |
| GliaPharm SA | 80% | |
| Astrocyte Pharmaceuticals Inc. | 75% | |
iQure Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 3, 2026 | ||||
| Series B | Jan 7, 2025 | ||||
| Series A | Nov 28, 2023 | ||||
| Series A | Oct 23, 2023 | ||||
| Series A | Sep 1, 2022 |
Key People
Founding team and executive leadership
iQure Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OKG Capital | Series A, Series B |
| Ventura BioMed Investors | Series A |
| Keiretsu Forum Mid-Atlantic | Series A |
| i&i Prague | Series B |
| Mass Medical Angels | Series A |
| Ventura BioMedical | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
$650K raised in Seed Round.
- Jul 2, 2025
Prof. Dr. Iris Loew-Friedrich appointed as advisor.
iQure Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iQure Pharma's valuation, stock price, and market status.